Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Ben-Joseph

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Economics|October 10, 2015
Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodoneRami Ben-Joseph, Jill A Bell, Abhishek Chitnis, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 29, 2011
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 20, 2011
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 5, 2011
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptionsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Current Medical Research and Opinion|February 10, 2015
Sources of prescription opioids among diagnosed opioid abusersAmie Shei, J Bradford Rice, Noam Y Kirson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 29, 2003
Cost, morbidity, and control of asthma in Hungary: The Hunair StudyIren Herjavecz, Gyorgy Boszormenyi Nagy, Kalman Gyurkovits, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Opioid Treatment Patterns Following Prescription of Immediate-Release HydrocodoneRami Ben-Joseph, Jill A Bell, Diana Brixner, et al.
Circulation|July 2, 2008
Prediction of first events of coronary heart disease and stroke with consideration of adiposityPeter W F Wilson, Samuel R Bozeman, Tanya M Burton, et al.
Pain Medicine (Malden, Mass.)|July 22, 2014
Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United StatesNoam Y Kirson, Amie Shei, Alan G White, et al.
Journal of Medical Economics|February 25, 2014
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the USLouis F Rossiter, Noam Y Kirson, Amie Shei, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|October 10, 2015
Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodoneRami Ben-Joseph, Jill A Bell, Abhishek Chitnis, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 29, 2011
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 20, 2011
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 5, 2011
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptionsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Current Medical Research and Opinion|February 10, 2015
Sources of prescription opioids among diagnosed opioid abusersAmie Shei, J Bradford Rice, Noam Y Kirson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 29, 2003
Cost, morbidity, and control of asthma in Hungary: The Hunair StudyIren Herjavecz, Gyorgy Boszormenyi Nagy, Kalman Gyurkovits, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Opioid Treatment Patterns Following Prescription of Immediate-Release HydrocodoneRami Ben-Joseph, Jill A Bell, Diana Brixner, et al.
Circulation|July 2, 2008
Prediction of first events of coronary heart disease and stroke with consideration of adiposityPeter W F Wilson, Samuel R Bozeman, Tanya M Burton, et al.
Pain Medicine (Malden, Mass.)|July 22, 2014
Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United StatesNoam Y Kirson, Amie Shei, Alan G White, et al.
Journal of Medical Economics|February 25, 2014
Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the USLouis F Rossiter, Noam Y Kirson, Amie Shei, et al.
Pageof 4